Pure Global

ONCOPROBE HCV Antibody Rapid Test - Indonesia BPOM Medical Device Registration

ONCOPROBE HCV Antibody Rapid Test is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 30305220651. The device is manufactured by FORMOSA BIOMEDICAL TECHNOLOGY CORP. from Taiwan (China), and is classified as Risk Class Kelas Resiko : D. The authorized representative in Indonesia is PT. MAIN ONCOPROBE.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : D
ONCOPROBE HCV Antibody Rapid Test
Analysis ID: AKL 30305220651

Risk Classification

Kelas Resiko : D

Product Class

Kelas : 3

Country of Origin

Taiwan (China)

Authorized Representative

PT. MAIN ONCOPROBE

AR Address

APRT.ISTANA HARMONI LT.DASAR UNIT 1M, KOMP.HARMONI PLAZA JL.SURYOPRANOTO NO.2, PETOJO UTARA

Registration Date

Jan 24, 2023

Expiry Date

Dec 31, 2025

Product Type

Immunological Test System

Antinuclear antibody immunological test system.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing